Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C8H6N2
CAS Number:
Molecular Weight:
130.15
EC Number:
202-047-4
UNSPSC Code:
41116107
PubChem Substance ID:
Beilstein/REAXYS Number:
109351
MDL number:
InChI key
XSCHRSMBECNVNS-UHFFFAOYSA-N
InChI
1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H
SMILES string
c1ccc2nccnc2c1
grade
analytical standard
assay
≥98.0% (GC)
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
bp
220-223 °C (lit.)
mp
29-32 °C (lit.)
density
1.124 g/mL at 25 °C (lit.)
application(s)
cleaning products
clinical
cosmetics
environmental
food and beverages
personal care
format
neat
storage temp.
2-8°C
Quality Level
General description
Quinoxaline is a synthetic non-nutritive feed additive, consisting of a quinoxaline ring moiety. The quinoxaline ring is part of a variety of antibiotics, namely actinomycin, levomycin, and echinomycin, which inhibit the growth of Gram-positive bacteria. It is also active against various transplantable tumors.
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Storage Class
11 - Combustible Solids
wgk
WGK 3
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Preparation of silver nanostructures from a new benzopyrazine silver (I) nitrate coordination polymer
Mollaee J, et al.
Inorganic Chemistry Communications, 43, 67-69 (2014)
Catalyst?Free Protocol for the Synthesis of Quinoxalines and Pyrazines in PEG
Huang Q-T, et al.
Journal of Heterocyclic Chemistry, 50(2), 293-297 (2013)
Determination of quinoxaline antibiotics in fish feed by enzyme-linked immunosorbent assay using a monoclonal antibody
Peng J, et al.
Analytical Methods : Advancing Methods and Applications, 7(12), 5204-5209 (2015)
Tony Antoniou et al.
Antiviral therapy, 19(6), 607-611 (2014-02-13)
We sought to determine the pharmacokinetic disposition of raltegravir in the blood and seminal plasma of HIV-infected men. We conducted a pharmacokinetic study using a staggered sampling approach. A total of 16 HIV-infected men receiving raltegravir-based therapy were recruited into
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service